US · Basic Materials · Agricultural Inputs
EPS came in at 0.12 against a street estimate of 0.11 — a beat of 9.1%.
Analysts rate ICL Israel Chemicals Ltd a hold (0 buy, 4 hold, 0 sell out of 4) with an average price target of $5.81.
MIXED Strong Q2 with sales +17% YoY and EBITDA +28%, driven by higher prices and volumes. Sulfur costs and FX headwinds threaten H2; company restructuring into 4 segments and launching $350M cost-cut program by 2028. Q2 2026 Brazil represents 1/3 of Growing Solutions; high interest rates (9%+ real), weak credit availability, and affordability challenges persist despite higher grain prices. Europe benefited from product mix optimization. Analysts pressed on Industrial Products durability (price vs. volume), Elevate credibility (productivity realism), and sulfur/Brazil risks. Management acknowledged headwinds are real but emphasized diversified portfolio, cost controls, and stable demand offsetting some impact; positioned second half as manageable but moderating. 2026-08-05…
Full summary in the app.
| Fund | Stake |
|---|---|
| Altshuler Shaham Ltd | 1.86% |
| Vanguard Capital Management, LLC | 1.62% |
| Clal Insurance Enterprises Holdings Ltd | 1.53% |
| Y.D. More Investments Ltd | 1.51% |
| Phoenix Financial Ltd | 1.21% |
| Morgan Stanley - Brokerage Accounts | 0.76% |
| Vanguard Fiduciary Trust Co | 0.50% |
| BlackRock Inc | 0.44% |
| Document | Date |
|---|---|
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • ICL Group held its 2026 Annual General Meeting on September 17, 2026. • Shareholders approved all proposals presented at the meet | 2026-09-17 |
| Current report (6-K) · Q3 2026 HEADLINE NUMBERS • ICL Group will distribute approximately $75 million in dividends from earnings. • Dividend per share: $0.05811 for payments in U. | 2026-09-01 |
| Quarterly results (6-K) · Q2 2026 HEADLINE NUMBERS • ICL will reorganize its business into four reportable segments starting January 1, 2027: Growing Solutions, Nutrition Solutions, I | 2026-08-05 |
| Quarterly results (6-K) · Q2 2026 HEADLINE NUMBERS • Q2 2026 total sales were $2.1 B, up 17% from Q2 2025 sales of $1,832 M. • Adjusted EBITDA was $448 M, up 28% from $351 M. • Adju | 2026-08-05 |
| Annual report FY2025 (20-F) HEADLINE NUMBERS • ICL Group Ltd. filed its Form 20-F annual report for the fiscal year ended December 31, 2025. • The company reports under Interna | 2026-03-11 |
| Annual report FY2024 (20-F) | 2025-03-13 |
| Annual report FY2023 (20-F) | 2024-03-14 |
| Annual report FY2022 (20-F) | 2023-02-28 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.06 / share ex-date Sep 2, 2026 · pay Sep 16, 2026 | 2026-09-02 |
| Dividend | $0.05 / share ex-date Jun 2, 2026 · pay Jun 17, 2026 | 2026-06-02 |
| Dividend | $0.05 / share ex-date Mar 10, 2026 · pay Mar 25, 2026 | 2026-03-10 |
| Dividend | $0.05 / share ex-date Dec 2, 2025 · pay Dec 17, 2025 | 2025-12-02 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for ICL Israel Chemicals Ltd — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.